FEN1 promotes tumor progression and confers cisplatin resistance in non-small-cell lung cancer.
He L, Luo L, Zhu H, Yang H, Zhang Y, Wu H, Sun H, Jiang F, Kathera CS, Liu L, Zhuang Z, Chen H, Pan F, Hu Z, Zhang J, Guo Z.
He L, et al. Among authors: hu z.
Mol Oncol. 2017 Jun;11(6):640-654. doi: 10.1002/1878-0261.12058. Epub 2017 May 12.
Mol Oncol. 2017.
PMID: 28371273
Free PMC article.